AJPB® Translating Evidence-Based Research Into Value-Based Decisions®
AJPB® The American Journal of Pharmacy Benefits® November 2024
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Enlicitide Decanoate Data Show Significant LDL-C Reductions in At-Risk Patients
2
Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases
3
FDA Approves Tarlatamab-Dlle to Treat Adults With Extensive Stage Small Cell Lung Cancer
4
Twice-Yearly Depemokimab Improves Peak Expiratory Flow and Asthma Symptoms
5
